Methylfolate Supplements Guide (2026): Evidence-Based Comparisons

By Erin Rose · Updated June 25, 2026 · Methodology · About Us

The dose gap nobody mentions

Methylfolate is sold for two very different reasons — as a better-absorbed everyday folate, and as something to take for depression. The second claim is the one that sells bottles, and it is the one where the dose on the shelf and the dose in the trials are not in the same range.

What the depression trials actually used: 15 mg a day. The research behind “methylfolate for depression” is a set of trials in people whose SSRI had not worked, given adjunctive L-methylfolate calcium at 15 mg daily. The pooled effect on the Hamilton depression scale was −2.74 points against placebo (95% CI −4.99 to −0.48, P = 0.017), and it concentrated in patients with obesity or raised inflammatory markers rather than appearing across the board (PMID 24813065; PMID 27035404).

What is on the shelf: 0.4 to 1.7 mg. The three products we track run 400 mcg, 1,000 mcg and 1,700 mcg per serving. The largest of them is 1.7 mg — roughly a ninth of the trial dose. Reaching 15 mg would mean taking nine of the strongest tablets a day, which is not what the label directs and not what anybody does.

That is not a reason to avoid methylfolate. It is a reason to be clear about which product you are buying and why: a 400–1,700 mcg tablet is a nutritional folate dose, in the range of the 400 mcg daily requirement. It is not the psychiatric intervention the trials tested, and no amount of marketing copy closes a ninefold gap. The 15 mg product used in those trials is a prescription medical food in the US, not a supplement.

Methylfolate or folic acid?

The case for methylfolate is that it is the form the body actually uses, so it does not depend on the MTHFR enzyme step that a common gene variant slows down. A pharmacokinetic study comparing the two found 5-methyltetrahydrofolate to be at least as good as folic acid at raising folate status (PMID 14769778), and it avoids the unmetabolised folic acid that accumulates at higher intakes.

But for the one folate indication with the strongest evidence behind it, the proven agent is folic acid. The evidence base for preventing neural tube defects — the reason folate is recommended before and during early pregnancy — was built on folic acid, and that is what the US Preventive Services Task Force reviewed and recommends (PMID 37526714). If you are pregnant or planning to be, that is not the place to substitute a form because it sounds more advanced. Ask your clinician rather than swapping on your own.

What methylfolate is actually better at

“The active form” is a marketing line, not a mechanism you can act on. The measurable advantage is narrower and more interesting: speed.

A pharmacokinetic study gave folate-insufficient women either 5-MTHF or folic acid and tracked serum folate. Total folate rose considerably faster over the first four days on 5-MTHF (P for trend <0.0001), and nearly all the women reaching for it hit 50 nM serum folate almost immediately — a level that could then be held with a routine 0.4 mg of folic acid daily (PMID 29511242). So the honest framing is that 5-MTHF is the better rescue, and folic acid is a perfectly good maintenance. If you are short and want to be topped up quickly, that is the case for it.

The other reason people choose it

Folic acid at higher intakes can appear unmetabolised in the bloodstream, and with staple foods fortified in many countries that exposure is chronic rather than occasional. The clearest documented risk is not exotic: unmetabolised folic acid can mask a vitamin B12 deficiency, correcting the anaemia while the neurological damage continues (PMID 9174474). Methylfolate sidesteps that pathway entirely, which is a reasonable thing to want even if you have never had your MTHFR status tested.

Two practical consequences. If you take folate of any kind long-term and are over 50, vegetarian, on metformin or on a proton-pump inhibitor — all groups with higher B12 depletion risk — check B12 alongside it rather than assuming a normal blood count means you are fine. And if you are choosing a form for everyday nutritional use rather than for pregnancy, methylfolate at 400–1,000 mcg is a defensible default with no real downside beyond price.

The three products we track

All are single-ingredient L-methylfolate. Note the fourfold spread in dose, which makes cost per day a misleading comparison on its own — the cheapest daily cost here also happens to be the largest dose.

Check price →

Common questions

Should I take methylfolate for depression?

Not on the basis of these products. The trials used 15 mg a day of prescription L-methylfolate as an add-on for people whose SSRI had failed, and found a modest effect concentrated in patients with obesity or inflammation. A 1,700 mcg supplement is about a ninth of that dose. If the depression indication is what you are after, it is a conversation with a prescriber, not a shelf purchase.

Do I need it if I have an MTHFR variant?

It is the reasonable choice if you want to bypass that conversion step, and a pharmacokinetic comparison supports it raising folate status at least as well as folic acid. What it is not is a treatment for the variant itself.

Is methylfolate better than folic acid in pregnancy?

The neural tube defect evidence, and the USPSTF recommendation built on it, is for folic acid. Do not substitute on your own reasoning here.

Which of these should I buy?

If you want a nutritional dose near the 400 mcg requirement, the Jarrow product is that dose. The Life Extension tablet is the cheapest per day and the largest dose, and the Thorne product is the only one carrying third-party certification. Match the dose to the reason first, then compare price.

About our data

Every comparison uses clinical evidence from PubMed systematic reviews, product label data from the NIH Dietary Supplement Label Database, and third-party certifications (USP, NSF). Products are ranked by cost per clinically-effective dose. See our methodology and editorial standards.